Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 278-780-9
CAS number: 77881-13-1
No mortalities occurred. Moreover, no
compound-related findings were observed in body weight gain or autopsy. Main
clinical findings were spastic gait and ruffled fur which were observed on
the first day after application in all dose groups. From day 2 onwards all
animals were without findings.
In an orientating toxicity study the single
oral administration of the test substance (ZK 74.804) to male rats at
doses of 0.25, 0.5, 1.0, 2.0, 3.5 and 5 g/kg was tolerated without any
mortality or compound-related macroscopic pathological signs. Main
clinical findings were spastic gait and ruffled fur which were observed
on the first day after application in all dose groups. From day 2
onwards all animals were without findings.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again